Bank of Montreal
NVLN

Bank of Montreal’s Novelion Therapeutics Inc. Common Shares NVLN Stock Holding History

Bank of Montreal’s Portfolio NVLN Stock Details NVLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-1,046
Closed -$1K – 5145
2019
Q3 		$1K Sell
1,046
-24
-2% -$17 ﹤0.01% 4696
2019
Q2 		$1K Sell
1,070
-60
-5% -$67 ﹤0.01% 4821
2019
Q1 		$1K Buy
1,130
+200
+22% +$228 ﹤0.01% 4251
2018
Q4 		$1K Hold
930
– – ﹤0.01% 4619
2018
Q3 		$2K Sell
930
-30
-3% -$106 ﹤0.01% 4460
2018
Q2 		$3K Sell
960
-310
-24% -$1.25K ﹤0.01% 4303
2018
Q1 		$4K Buy
1,270
+100
+9% +$424 ﹤0.01% 3975
2017
Q4 		$4K Sell
1,170
-335
-22% -$1.61K ﹤0.01% 3983
2017
Q3 		$11K Sell
1,505
-672
-31% -$5.38K ﹤0.01% 3681
2017
Q2 		$21K Buy
2,177
+1,171
+116% +$11.3K ﹤0.01% 3531
2017
Q1 		$11K Hold
1,006
– – ﹤0.01% 3535
2016
Q4 		$10K Buy
+1,006
New +$8.91K ﹤0.01% 3617

Other funds holding NVLN

SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return
DMK
David M. Knott $275M AUM 59.23% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
FSA
Franklin Street Advisors Chapel Hill, North Carolina $1.79B AUM 28.1% 1-Year Est. Return

Bank of Montreal's NVLN Position: Q4 2019 in Review

Bank of Montreal sold out of Novelion Therapeutics Inc. Common Shares (NVLN) in Q4 2019, closing a stake of 1,046 shares — an estimated $1K sold.

Bank of Montreal first reported a position in NVLN in Q4 2016 and held it in 12 quarters. The position peaked at $21K in Q2 2017. 7 funds tracked by Wall St. Rank hold NVLN as of Q4 2019.

  • Bank of Montreal reported no remaining Novelion Therapeutics Inc. Common Shares position as of Q4 2019 after selling out during the quarter.
  • Bank of Montreal sold 1,046 Novelion Therapeutics Inc. Common Shares shares in Q4 2019, an estimated $1K.
  • Bank of Montreal first reported a position in Novelion Therapeutics Inc. Common Shares in Q4 2016 and held it in 12 quarters.
  • Bank of Montreal's Novelion Therapeutics Inc. Common Shares position peaked at $21K in Q2 2017.
  • 7 funds tracked by Wall St. Rank held Novelion Therapeutics Inc. Common Shares as of Q4 2019.

Based on Bank of Montreal's 13F filing for Q4 2019, filed 10 Feb 2020.